This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.
EClinicalMedicine, 76, 102799
Citation
Erritzoe, David; Barba, Tommaso; Greenway, Kyle T; Murphy, Roberta; Martell, Jonny; Giribaldi, Bruna; Timmermann, Christopher; Murphy-Beiner, Ashleigh; Jones, Michelle Baker; Nutt, David; Weiss, Brandon; Carhart-Harris, Robin. (2024). Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.. EClinicalMedicine, 76, 102799. https://doi.org/10.1016/j.eclinm.2024.102799